Yuqiang Mi

机构：Xuzhou Medical College, Second People’s Hospital of Huai’an · ORCID：0000-0001-7809-2679

发表论文 86 篇 · 总被引 2234 次 · h-index 17

代表论文

• Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD (2025 · Clinical Gastroenterology and Hepatology · 被引 29)
• Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study (2025 · Cell Reports Medicine · 被引 29)
• ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43/AMPK pathway (2023 · Lipids in Health and Disease · 被引 17)
• Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease (2024 · World Journal of Gastroenterology · 被引 13)
• Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma (2024 · Cancer Biology and Medicine · 被引 10)
• Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC (2024 · Cancer Gene Therapy · 被引 7)